TF

The Falck Revocable Trust

Description

The Falck Revocable Trust

Investor Profile

The Falck Revocable Trust has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B rounds (top funding stages).
  • Majority of deals are located in Germany.
  • Strong thematic focus on Health Care, Medical, Therapeutics.

Stage Focus

  • Series C (50%)
  • Series B (50%)

Country Focus

  • Germany (100%)

Industry Focus

  • Health Care
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does The Falck Revocable Trust frequently co-invest with?

RV
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
KfW
Europe, Hessen, Germany, Frankfurt
Co-Investments: 2
SMS Group
Europe, Nordrhein-Westfalen, Germany, Düsseldorf
Co-Investments: 2
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 1
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 1
VF
Europe, Berlin, Germany, Berlin
Co-Investments: 2
Vesalius Biocapital Partners
Europe, Luxembourg, Luxembourg, Strassen
Co-Investments: 2
AG
Europe, Bayern, Germany, Munich
Co-Investments: 1
Co-Investments: 1
KG Investments
North America, Arizona, United States, Scottsdale
Co-Investments: 1

What are some of recent deals done by The Falck Revocable Trust?

OMEICOS Therapeutics

Berlin, Berlin, Germany

OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.

Health CareMedicalTherapeutics
Series CNov 2, 2018
Amount Raised: $19,357,777
OMEICOS Therapeutics

Berlin, Berlin, Germany

OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.

Health CareMedicalTherapeutics
Series BMar 1, 2017
Amount Raised: $8,744,832